Sports Medicine: Just the Facts

(やまだぃちぅ) #1

148 SECTION 3 • MEDICAL PROBLEMS IN THE ATHLETE


ARRHYTHMIAS IN ATHLETES



  • Lethal cardiac arrhythmias represent the most serious
    risk for sudden death in athletes. Symptoms of a
    potential arrhythmia may include syncope, near syn-
    cope, palpitations, exertional chest discomfort, severe
    dyspnea, or uncommon exertional fatigue.


EVALUATION



  • Structural heart disease must be ruled out before the
    athlete is allowed to return to sports (Maron and
    Mitchell, 1994; Kugler and O’Connor, 1999;
    Luckstead, 2002). This will include a meticulous his-
    tory, physical examination, and EKG and may be fol-
    lowed by chest X-ray, echocardiogram, stress test,
    Holter monitoring, electrolytes, and other laboratory
    testing.

  • It may very well include early referral to a cardiolo-
    gist for electrophysiologic study and/or ongoing man-
    agement.


SPORTS PARTICIPATION

•Various arrhythmias are compatible with competi-
tive sports once they are diagnosed and controlled.
See Table 25-10 for a summary of the common dys-
rhythmias and the recommendations from the 26th
Bethesda Conference (Maron and Mitchell, 1994).


  • The Committee on Sports Medicine and Fitness for
    the American Academy of Pediatrics specifically
    recommends that the presence of a symptomatic
    dysrhythmia requires exclusion from physical
    activity until the athlete’s problem can be ade-
    quately evaluated by a cardiologist and controlled
    (Committee on Sports Medicine and Fitness, 1995).


REFERENCES


American College of Sports Medicine: ACSM’s Guidelines for
Exercise Testing and Prescription,6th ed. Philadelphia, PA,
Lippincott Williams, and Wilkins, 2000, pp 165–199.
Basilico FC: Cardiovascular disease in athletes. Am J Sports Med
27:108–121, 1999.
Berlin JA, Colditz GA: A meta-analysis of physical activity in the
prevention of coronary heart disease. Am J Epidemiol
132:612–628, 1990.
Blair SN, Kohl HW III, Barlow CE, et al: Changes in physical fit-
ness and all-cause mortality: A prospective study of healthy
and unhealthy men. JAMA. 273:1093–1098, 1995.
Cantu RC: Congenital cardiovascular disease: The major cause of
athletic death in high scool and college. Med Sci Sports Exerc
24:279–280, 1992.
Committee on Sports Medicine and Fitness: Cardiac dysrhyth-
mias and sports. Pediatrics95:786–789, 1995.
Committee on Sports Medicine and Fitness: Athletic participa-
tion by children and adolescents who have systemic hyperten-
sion. Pediatrics99(4), 1997.
Firoozi S, Sharma S, Hamid MS, et al: Sudden death in young ath-
letes: HCM or ARVC? Cardiovasc Drugs Ther16:11–17, 2002.
Fuentes RJ, Rosenberg JM, Davis A (eds.): Athletic Drug refer-
ence ‘96. Durham, NC, Clean Data, 1996.
Huston TP, Puffer JC, Rodney WM: The athletic heart syndrome.
N Engl J Med313:24–32, 1985.
Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure: The seventh report of
the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure. JAMA
289:2560–2572, 2003.
Kapoor WN: Evaluation and management of the patient with syn-
cope. JAMA268:2553–2560, 1992.
Kohl HW III, Powell KE, Gordon NF, et al: Physical activity,
physical fitness, and sudden cardiac death. Epidemiol Rev
14:37–58, 1992.
Kugler JP, O’Connor FG: Cardiovascular problems, in Lillegard
WA, Butcher JD, Rucker KS, (eds.): Handbook of Sports Medi-
cine, 2nd ed. Boston, MA, Butterworth/Heinemann, 1999, p 339.

TABLE 25-10 Activity Recommendations
for the Common Dysrhythmias


ACTIVITY RECOMMENDATIONS


Disturbances of sinus node No symptoms, no treatment; if
function (includes sinus symptoms require pacemaker, then
bradycardia, tachycardia, no collision sports
arrhythmia, arrest, exit
block; sick sinus syndrome)
Premature atrial complexes No restrictions
Atrial flutter and atrial If no structural heart disease and rate
fibrillation controlled by drugs, then
low-intensity sports; if no flutter or
fibrillation for 6 months, then full
participation
Supraventricular tachycardia If episodes are prevented by drugs,
then full participation; if structural
disease and if syncope or
pre-syncope, no competitive sports;
reconsider after 6 mos without
recurrence
Ventricular pre-excitation If no structural heart disease and no
(WPW) symptoms, then no limit; if
structuralheart disease and PVCs
worsen with exercise, restrict;
PVCs plus prolonged QT interval
should be restricted (high risk for
sudden death)
Heart blocks (first-degree or If no symptoms and no structural
Mobitz I second-degree) disease, then no restrictions
Heart blocks (Mobitz II If no symptoms and no structural
second degree or third disease, then no restrictions if rate
degree) 40–80; if symptoms then pacer and
avoid collision sports
Congenital long Q-T Restrict from all competitive sports
Syndrome (High risk for death)


SOURCE: (Maron and Mitchell, 1994; Kugler and O’Connor, 1999)

Free download pdf